Poloxamer 188 Attenuates Cerebral Hypoxia/Ischemia Injury in Parallel with Preventing Mitochondrial Membrane Permeabilization and Autophagic Activation
- 13 May 2015
- journal article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 56 (4) , 988-998
Abstract
While the previous studies have shown poloxamer 188 (P188)’s neuroprotection in cultured HT22 cells under oxygen–glucose deprivation (OGD) insults, we investigated whether P188 is a potential neuroprotective agent in primary cortical neurons (PCNs) and in cerebral ischemia in vivo and whether the possible underlying mechanisms correlate with regulating mitochondrial membrane permeability (MMP) and autophagy. The protective effects of P188 were tested in PCNs in vitro exposed to OGD, as well as in cerebral ischemia in vivo. Cell death and viability were detected with LDH and MTT assay, and mitochondrial membrane potential was assessed using fluorescence microscopy. The apoptosis and autophagy of PCNs were investigated by expressions of cyt-c, caspase-3, light chain 3 (LC3), and Beclin-1. In addition, a mouse middle cerebral artery occlusion (MCAO) model was used to produce focal ischemia, and mice were treated with P188 and rapamycin after MCAO 10 min. The infarct volume, neurological scores, and phosphorylation of mammalian target of rapamycin (mTOR) were evaluated. The in vitro results showed that P188 prevented OGD-induced primary cerebrocortical neuron death and inhibited loss of mitochondrial membrane potential, the release of mitochondrial apoptogenic factor cytochrome c from mitochondria to the cytoplasm, and activation of caspase-3. P188 suppressed the activation of autophagy by decreasing LC3-II and Beclin-1 levels under OGD accordingly. Moreover, the in vivo results showed that P188 and rapamycin remarkably reduced the infarct volume and neurological deficits in the MCAO mouse model of cerebral ischemia, respectively. Both P188 and rapamycin induced phosphorylation of mTOR and reversed the decreased level upon MCAO. These data indicate that P188 prevents neuronal cell death resulting from ischemic brain injury and that its neuroprotective effects are mediated by preventing mitochondrial membrane integrity damage and autophagic activation. Given that it has low toxicity, P188 might become a potential novel therapy for ischemic injury.Keywords
This publication has 42 references indexed in Scilit:
- Poloxamer 188 Protects Neurons against Ischemia/Reperfusion Injury through Preserving Integrity of Cell Membranes and Blood Brain BarrierPLOS ONE, 2013
- Propofol Prevents Autophagic Cell Death following Oxygen and Glucose Deprivation in PC12 Cells and Cerebral Ischemia-Reperfusion Injury in RatsPLOS ONE, 2012
- Mitochondrial Injury after Mechanical Stretch of Cortical Neurons in vitro : Biomarkers of Apoptosis and Selective Peroxidation of Anionic PhospholipidsJournal of Neurotrauma, 2012
- Kollidon VA64, a Membrane-Resealing Agent, Reduces Histopathology and Improves Functional Outcome after Controlled Cortical Impact in MiceJournal of Cerebral Blood Flow & Metabolism, 2011
- Combination Therapy Targeting Akt and Mammalian Target of Rapamycin Improves Functional Outcome after Controlled Cortical Impact in MiceJournal of Cerebral Blood Flow & Metabolism, 2011
- mTOR Mediates Wnt-Induced Epidermal Stem Cell Exhaustion and AgingCell Stem Cell, 2009
- Mechanisms of ischemic brain damageNeuropharmacology, 2008
- No death without life: vital functions of apoptotic effectorsCell Death & Differentiation, 2008
- Nortriptyline Protects Mitochondria and Reduces Cerebral Ischemia/Hypoxia InjuryStroke, 2008
- Upstream of the mammalian target of rapamycin: do all roads pass through mTOR?Oncogene, 2006